Indonesia’s pharmaceutical sector continues to grow at a remarkable pace, offering significant opportunities while also presenting complex regulatory and intellectual property considerations. This session will provide a clear, practical overview of market entry pathways, compliance expectations, and strategies to safeguard innovation.
The program features three sessions, each sharing insights drawn from their extensive experience in market access, regulatory affairs, and IP protection.
You can view the full agenda here.
Register here.